Neumora Therapeutics, Inc.   Report issue

For profit Phase 2
Founded: South San Francisco CA United States (2013)

Organization Overview

First Clinical Trial
2013
NCT01263236
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

BlackThorn Therapeutics | BlackThorn Therapeutics, Inc. | BlackThorn Therapeutics, Inc. (Sponsor)